image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Hill & Smith - Infrastructure investment and CHIPS Act provides terrific US opportunity

July 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • HILS
  • Price:
  • 1480p
The USA narrowly avoided a catastrophic debt default in the eleventh hour.  However, the debt is on a wild ride and is projected to soar to staggering heights from just under 100% of GDP pre-pandemic to a mind-boggling 129% by 2025 and a jaw-dropping 195% by 2053. That's almost twice the size of the entire economy in just three decades.   Where some see turmoil others see investment opportunities opening up. For instance President Biden has spent trillions on COVID relief, student debt forgiveness, and renewable energy subsidies but there have also been critical investments that signify a recognition of the nation's infrastructure needs and the importance of bolstering national security, in particular there is the US$1.2 trillion ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author